Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Vigil Neuroscience, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +4 vs. Q3 2022
- Shares held
- 25.0M
- +429.2K (+1.7%) vs. Q3 2022
- Total value
- $312.3M
- +$89.6M (+40.2%) vs. Q3 2022
- New holders
- 9
- 12 more added
- Sold out
- 5
- 7 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $73.0M | 8.79% | 00.0% | Unchanged |
| Northpond Ventures, LLC | 4,214,498 | $52.7M | 28.58% | 00.0% | Unchanged |
| Artal Group S.A. | 2,243,352 | $28.0M | 1.62% | −42,222−1.8% | Reduced |
| Citadel Advisors LLC | 2,163,916 | $27.0M | 0.03% | −2,551−0.1% | Reduced |
| Deep Track Capital, LP | 2,104,174 | $26.3M | 1.15% | −259,014−11.0% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 2,052,010 | $25.7M | 0.53% | −2,784−0.1% | Reduced |
| BVF Inc | 1,813,633 | $22.7M | 0.96% | 00.0% | Unchanged |
| Vanguard Group Inc | 737,013 | $9.21M | 0.00% | +371,587+101.7% | Added |
| Cormorant Asset Management, LP | 616,786 | $7.71M | 0.52% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $7.01M | 3.05% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $5.90M | 0.14% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 448,891 | $5.61M | 0.11% | +37,700+9.2% | Added |
| Harvard Management Co Inc | 289,460 | $3.62M | 0.46% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 192,973 | $2.41M | 4.97% | +192,973 | New |
| Logos Global Management LP | 188,390 | $2.35M | 0.28% | −17,205−8.4% | Reduced |
| DAFNA Capital Management LLC | 168,846 | $2.11M | 0.59% | −47,549−22.0% | Reduced |
| Laurion Capital Management LP | 130,200 | $1.63M | 0.05% | 00.0% | Unchanged |
| Barclays PLC | 105,893 | $1.32M | 0.00% | +3,730+3.7% | Added |
| Geode Capital Management, LLC | 103,767 | $1.30M | 0.00% | +31,948+44.5% | Added |
| BlackRock Inc. | 102,391 | $1.28M | 0.00% | +666+0.7% | Added |
| Citigroup Inc | 93,927 | $1.17M | 0.00% | +26,272+38.8% | Added |
| FMR LLC | 86,650 | $1.08M | 0.00% | +59,695+221.5% | Added |
| Goldman Sachs Group Inc | 73,011 | $912.6K | 0.00% | −130.0% | Reduced |
| Bank of Montreal | 58,100 | $726.3K | 0.00% | +58,100 | New |
| State Street Corp | 35,739 | $446.7K | 0.00% | +14,365+67.2% | Added |
| Susquehanna International Group, LLP | 27,375 | $342.2K | 0.00% | +27,375 | New |
| Northern Trust Corp | 18,794 | $234.9K | 0.00% | +6,712+55.6% | Added |
| 683 Capital Management, LLC | 15,092 | $188.7K | 0.02% | +15,092 | New |
| Bank of America Corp | 9,896 | $123.7K | 0.00% | +9,896 | New |
| Morgan Stanley | 9,092 | $113.7K | 0.00% | +8,962+6,893.8% | Added |
| Cannell Capital LLC | 8,044 | $100.5K | 0.02% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,832 | $23.0K | 0.00% | +1,832 | New |
| UBS Group AG | 510 | $6.38K | 0.00% | +510 | New |
| State of Wyoming | 104 | $1.30K | 0.00% | +58+126.1% | Added |
| Wells Fargo & Company | 85 | $1.06K | 0.00% | +31+57.4% | Added |
| Coppell Advisory Solutions LLC | 300 | – | – | +300 | New |
| Coppell Advisory Solutions Corp. | 300 | – | – | +300 | New |
| Ergoteles LLC | 0 | $0 | 0.00% | −28,533−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −22,269−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −15,788−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |